🧬 SinoBioData Academic Portal
Open AccessDOI: 10.3724/abbs.2025008Original Research

p53-dependent chromatin relaxation is required for DNA double-strand break repair

🇨🇳 Original Chinese Title: p53-dependent chromatin relaxation is required for DNA double-strand break repair

Hongyu Chen¹,Jin Shan¹,Wenjing Qi¹,Lili Chen¹,Xianlu Zeng¹

The Key Laboratory of Molecular Epigenetics of Ministry of Education, Institute of Genetics and Cytology, Northeast Normal University

Read Executive PreviewQuick FAQ
p53-dependent chromatin relaxation is required for DNA double-strand break repair
Graphical Abstract / Figure
Published In
Acta Biochimica et Biophysica Sinica
Published:2025Edition:Vol. 57, Issue 5 • pp. 701-711Citation:Hongyu Chen et al. (2025), Acta Biochimica et Biophysica Sinica
Impact FactorPremier Chinese Biomedical Journal indexed in SinoBioData: Acta Biochimica et Biophysica Sinica (生物化学与生物物理学报).
Sponsored Research Partner

Key Takeaways & Executive Findings

  • • p53 is rapidly recruited to DNA double-strand break sites and surrounding chromatin, where it promotes chromatin relaxation to enhance DSB repair efficiency. • This novel function of p53 in DSB repair is independent of its canonical role as a transcriptional regulator, representing a paradigm shift in understanding p53's DNA damage response. • The study demonstrates that p53's direct involvement in chromatin remodeling extends beyond nucleotide excision repair to double-strand break repair, highlighting its broader role in genome stability. • These findings suggest potential therapeutic targets for enhancing DNA repair in cancer cells by modulating p53-dependent chromatin relaxation.
Sponsored Research Highlight

Abstract

The tumor suppressor p53, an indispensable nuclear transcription factor, plays a central role in orchestrating cellular responses when DNA damage occurs. In this study, we demonstrate that in the initial phases of DNA double-strand break (DSB) repair, p53 is rapidly recruited to sites of damage and the surrounding chromatin, where it enhances DSB repair efficiency. This enhancement occurs through the modulation of chromatin dynamics and the promotion of a more relaxed chromatin configuration, a process influenced by p53 in response to DSB-inducing factors such as etoposide, ultraviolet radiation, and nucleases. These results underscore the pivotal function of p53 as a rapid responder to DSBs, delineating a significant departure from its traditionally recognized role as a downstream transcriptional regulator in DNA damage repair processes. This study emphasizes that the direct engagement of p53 in DNA repair through chromatin structure regulation extends beyond its established involvement in UV irradiation-induced nucleotide excision repair (NER), demonstrating analogous mechanistic attributes in the context of DSB repair. This newly illuminated perspective enhances our understanding of the multifaceted roles of p53 in genome stability and integrity.

1. Introduction

DNA, while being a comparatively stable organic molecule, is perpetually exposed to a multitude of endogenous and exogenous damaging agents. In response to this relentless challenge, cells have developed an intricate array of biochemical pathways designed to mitigate such threats [1,2]. This advanced regulatory network is collectively referred to as the DNA damage response (DDR), which orchestrates a variety of critical biological outcomes, such as cell cycle arrest, DNA repair, apoptosis, and cellular senescence [3]. The components of the DDR are strategically classified into sensors, signal transducers, and effectors to address cellular challenges efficiently. A DNA double-strand break (DSB) represents a significant challenge for cells, with accurate repair being crucial for maintaining cellular survival and preventing oncogenic translocations [4]. A paradigmatic example of the organizational structure of the DDR is the recruitment of the MRN (MRE11-RAD50-NBS1) complex to DSB sites. The MRN complex is instrumental in recruiting and activating the ataxia telangiectasia mutated (ATM) kinase, which is pivotal in the DDR. In response to DNA damage, ATM transitions from an inactive dimer to an active monomer through autophosphorylation at key serine residues, such as S1981 [5]. Once activated at a damage site, ATM phosphorylates H2AX at S139, producing γ-H2AX, which in turn recruits MDC1, establishing a feedback loop that enhances ATM signaling by attracting more MRN complexes and ATM molecules [6]. This activation cascade also involves other critical factors, such as 53BP1, BRCA1, and the ubiquitin ligases RNF8 and RNF168 [7,8]. Among the most prolific ATM substrates, the tumor suppressor p53 is at the top [9].

DSB repair involves two major pathways: homologous recombination (HR) and nonhomologous end-joining (NHEJ). The key difference between HR and NHEJ is that HR is recruited exclusively during the S and G2 phases of the cell cycle; in contrast, NHEJ can be activated during all cell cycle phases [10,11]. HR is an error-free repair mechanism that uses a homologous template to accurately reassemble damaged DNA strands. Key proteins in HR include the MRN complex, BRCA1/BRCA2, ATM, and ATR, which are essential for initiating and regulating this process [11]. Conversely, NHEJ lacks a homologous template, directly rejoining DNA ends and thus being inherently error prone. Critical NHEJ factors include the Ku70/Ku80 complex, DNA-dependent protein kinases, and XRCC4, which are pivotal in this repair pathway [10]. The eukaryotic DSB response takes place on chromatin near the break site; thus, the basic organization of eukaryotic chromatin needs to be considered. Chromatin relaxation is considered a fundamental pathway in the DNA damage response [12].

P53 was initially found to be associated with the T antigen of simian virus 40 in rodent cells that had undergone transformation [13], and its function as a tumor suppressor was first acknowledged in 1989 [14,15]. Under nonstressful conditions, the E3 ubiquitin ligase MDM2 maintains minimal p53 levels [16,17]. However, with the activation of cellular stress, p53 becomes phos...

SinoBioData Interactive Document Reader
Page 1–5 of Preview
100%
Download Full PDF

Loading authentic research manuscript (Pages 1–5)...

Sponsored Research Partner
Cite This Research Paper
Hongyu Chen, Jin Shan, Wenjing Qi, Lili Chen, Xianlu Zeng (2026). p53-dependent chromatin relaxation is required for DNA double-strand break repair. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2025008
SinoBioData Academic & Legal Disclaimer

Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.

Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.

Frequently Asked Questions

What is the role of p53 in DNA double-strand break repair?

The study demonstrates that p53 is rapidly recruited to DNA double-strand break sites and surrounding chromatin, where it promotes chromatin relaxation, thereby enhancing the efficiency of DSB repair. This function is independent of its canonical role as a transcriptional regulator.

How does p53 influence chromatin structure during DNA repair?

p53 modulates chromatin dynamics by promoting a more relaxed chromatin configuration at damage sites, which facilitates the access of repair machinery to the DNA breaks.

What are the two major pathways for DNA double-strand break repair?

The two major pathways are homologous recombination (HR), which is error-free and active during S and G2 phases, and nonhomologous end-joining (NHEJ), which is error-prone and active throughout the cell cycle.

What is the significance of this study for cancer therapy?

By revealing a novel function of p53 in DSB repair through chromatin relaxation, this study suggests potential therapeutic targets for enhancing DNA repair in cancer cells, which could improve the efficacy of DNA-damaging treatments.

How does this study extend previous knowledge of p53 in DNA repair?

Previously, p53 was known to be involved in nucleotide excision repair (NER) after UV irradiation. This study shows that p53 also plays a direct role in DSB repair via chromatin remodeling, indicating a broader role in maintaining genome stability.

Recommended Scientific Literature & Research Partners

Related Technical Papers & Translations

Research Paper
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.

Read Abstract & PDF
Research Paper
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.

Read Abstract & PDF
Research Paper
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.

Read Abstract & PDF